Related Experiment Video
Updated: Jun 21, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological
Jianjun Liu1, Xiumei Xing, Haiyan Huang
1Key Laboratory of Modern Toxicology of Shenzhen, Shenzhen Center for Disease Control and Prevention, No. 21, Rd 1st Tianbei, 518020 Shenzhen, PR China.
Abstract:
Although many studies indicated that trichloroethylene (TCE) could induce autoimmune diseases and some protein adducts were detected, the proteins were not identified and mechanisms remain unknown. To screen and identify autoantigens which might be involved in TCE-induced autoimmune diseases, three groups of sera were collected from healthy donors (I), patients suffering from TCE-induced exfoliative dermatitis (ED) (II), and the healed ones (III). Serological proteome analysis (SERPA) was performed with total proteins of TCE-treated L-02 liver cells as antigen sources and immunoglobins of the above sera as probes. Highly immunogenic spots (2-fold or above increase compared with group I) in group II and III were submitted to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and tandem mass spectrometry sequencing. Western blot analysis was followed using commercial antibodies and individual serum. Six proteins were identified. Among them, Enoyl Coenzyme A hydratase peroxisoma 1 and lactate dehydrogenase B only showed stronger immunogenicity for group II sera, while Purine nucleoside phosphorylase, ribosomal protein P0 and proteasome activator subunit1 isoform1 also showed stronger immunogenicity for group III sera. Noteworthy, NM23 reacted only with group II sera. Western blot analysis of NM23 expression indicated that all of the individual serum of group II showed immune activity, which confirmed the validity of SERPA result. These findings revealed that there exist autoantibodies in group II and III sera. Besides, autoantibodies of the two stages of disease course were different. These autoantigens might serve as biomarkers to elucidate mechanisms underlying TCE toxicity and are helpful for diagnosis, therapy and prognosis of TCE-induced autoimmune diseases.
Insights
Trichloroethylene (TCE) exposure can trigger autoimmune diseases. Researchers identified specific autoantigens in patients with TCE-induced dermatitis, revealing distinct antibody profiles during disease stages for potential diagnostic biomarkers.
Area of Science:
- Toxicology
- Immunology
- Proteomics
Background:
- Trichloroethylene (TCE) is linked to autoimmune diseases, but underlying mechanisms and specific autoantigens remain unidentified.
- Previous research detected protein adducts but failed to identify the specific proteins involved in TCE-induced autoimmunity.
Purpose of the Study:
- To screen and identify autoantigens implicated in trichloroethylene-induced autoimmune diseases.
- To investigate differences in autoantibody profiles between active disease and healed stages.
Main Methods:
- Serological proteome analysis (SERPA) was employed using sera from healthy donors, TCE-induced exfoliative dermatitis patients, and healed patients.
- Proteins with high immunogenicity were identified using MALDI-TOF-MS and tandem mass spectrometry.
- Western blot analysis confirmed the reactivity of identified autoantigens with patient sera.
Main Results:
- Six autoantigens were identified, including Enoyl Coenzyme A hydratase peroxisoma 1, lactate dehydrogenase B, Purine nucleoside phosphorylase, ribosomal protein P0, proteasome activator subunit 1 isoform 1, and NM23.
- NM23 showed reactivity exclusively with sera from patients with active TCE-induced dermatitis.
- Distinct autoantibody profiles were observed between active disease and healed stages.
Conclusions:
- The study identified specific autoantigens associated with trichloroethylene-induced autoimmune diseases.
- Autoantibody profiles differ between active and healed stages of the disease, suggesting potential biomarkers for diagnosis and prognosis.
- These findings contribute to understanding TCE toxicity mechanisms and offer insights for clinical management.
